Guangdong Kanghua Healthcare Group Beheer
Beheer criteriumcontroles 4/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Wangzhi Chen
Algemeen directeur
CN¥1.5m
Totale compensatie
| Percentage CEO-salaris | 85.7% |
| Dienstverband CEO | 8.9yrs |
| Eigendom CEO | n/a |
| Management gemiddelde ambtstermijn | 8.4yrs |
| Gemiddelde ambtstermijn bestuur | 8.9yrs |
Recente managementupdates
Shareholders May Find It Hard To Justify Increasing Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) CEO Compensation For Now
Jun 19
Key Things To Understand About Guangdong Kanghua Healthcare's (HKG:3689) CEO Pay Cheque
Dec 14Recent updates
There May Be Some Bright Spots In Guangdong Kanghua Healthcare Group's (HKG:3689) Earnings
Sep 30Shareholders May Find It Hard To Justify Increasing Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) CEO Compensation For Now
Jun 19Does Guangdong Kanghua Healthcare (HKG:3689) Deserve A Spot On Your Watchlist?
Jun 10Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) Share Price Boosted 28% But Its Business Prospects Need A Lift Too
May 22Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal
Nov 28Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)
May 09Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal
Feb 02Here's Why Guangdong Kanghua Healthcare (HKG:3689) Can Manage Its Debt Responsibly
Nov 08Some Investors May Be Worried About Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital
Sep 06Investors Could Be Concerned With Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital
May 31Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)
Jan 25Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal
Sep 21Is Guangdong Kanghua Healthcare (HKG:3689) Using Too Much Debt?
May 03Do Insiders Own Lots Of Shares In Guangdong Kanghua Healthcare Co., Ltd. (HKG:3689)?
Feb 04
Key Things To Understand About Guangdong Kanghua Healthcare's (HKG:3689) CEO Pay Cheque
Dec 14Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥51m |
| Mar 31 2024 | n/a | n/a | CN¥86m |
| Dec 31 2023 | CN¥1m | CN¥1m | CN¥121m |
| Sep 30 2023 | n/a | n/a | CN¥118m |
| Jun 30 2023 | n/a | n/a | CN¥115m |
| Mar 31 2023 | n/a | n/a | CN¥87m |
| Dec 31 2022 | CN¥2m | CN¥1m | CN¥60m |
| Sep 30 2022 | n/a | n/a | CN¥59m |
| Jun 30 2022 | n/a | n/a | CN¥59m |
| Mar 31 2022 | n/a | n/a | CN¥76m |
| Dec 31 2021 | CN¥2m | CN¥1m | CN¥94m |
| Sep 30 2021 | n/a | n/a | CN¥103m |
| Jun 30 2021 | n/a | n/a | CN¥112m |
| Mar 31 2021 | n/a | n/a | CN¥43m |
| Dec 31 2020 | CN¥2m | CN¥2m | -CN¥25m |
| Sep 30 2020 | n/a | n/a | -CN¥63m |
| Jun 30 2020 | n/a | n/a | -CN¥100m |
| Mar 31 2020 | n/a | n/a | -CN¥13m |
| Dec 31 2019 | CN¥2m | CN¥2m | CN¥74m |
| Sep 30 2019 | n/a | n/a | CN¥112m |
| Jun 30 2019 | n/a | n/a | CN¥150m |
| Mar 31 2019 | n/a | n/a | CN¥159m |
| Dec 31 2018 | CN¥2m | CN¥2m | CN¥168m |
| Sep 30 2018 | n/a | n/a | CN¥169m |
| Jun 30 2018 | n/a | n/a | CN¥170m |
| Mar 31 2018 | n/a | n/a | CN¥163m |
| Dec 31 2017 | CN¥1m | CN¥792k | CN¥157m |
Compensatie versus markt: De totale vergoeding ($USD 202.81K ) Wangzhi } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de Hong Kong markt ($USD 232.62K ).
Compensatie versus inkomsten: De vergoeding van Wangzhi is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Wangzhi Chen (53 yo)
8.9yrs
Tenure
CN¥1,470,000
Compensatie
Mr. Wangzhi Chen is Co-Owner of Dongguan Xingda Property Investment Co., Ltd. Mr. Chen serves as Chief Executive Officer of Guangdong Kanghua Healthcare Co., Ltd. Mr. Chen has been Executive Director at Gu...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Executive Chairman of the Board | 8.9yrs | CN¥180.00k | 66.54% HK$ 478.4m | |
| CEO & Executive Director | no data | CN¥1.47m | geen gegevens | |
| Executive Vice Chairman | 8.9yrs | CN¥180.00k | geen gegevens | |
| Executive Director | no data | CN¥303.00k | geen gegevens | |
| CFO, Joint Company Secretary & Secretary to the Board | 8.9yrs | geen gegevens | geen gegevens | |
| Vice General Manager of Operation | 8.4yrs | geen gegevens | geen gegevens | |
| Joint Company Secretary | 8.4yrs | geen gegevens | geen gegevens | |
| Financial Controller | 8.4yrs | geen gegevens | geen gegevens |
8.4yrs
Gemiddelde duur
48.5yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van 3689 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 8.4 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Executive Chairman of the Board | 8.9yrs | CN¥180.00k | 66.54% HK$ 478.4m | |
| CEO & Executive Director | 8.9yrs | CN¥1.47m | geen gegevens | |
| Executive Vice Chairman | 8.9yrs | CN¥180.00k | geen gegevens | |
| Executive Director | 8.9yrs | CN¥303.00k | geen gegevens | |
| Independent Non-Executive Director | 8.4yrs | CN¥120.00k | geen gegevens | |
| Independent Non-Executive Director | 8.9yrs | CN¥120.00k | geen gegevens | |
| Non-Executive Director | 8.4yrs | geen gegevens | geen gegevens | |
| Independent Non-Executive Director | 8.4yrs | CN¥120.00k | geen gegevens | |
| Chairman of the Supervisory Committee | 8.9yrs | geen gegevens | geen gegevens | |
| Member of Supervisory Committee | 8.9yrs | geen gegevens | geen gegevens | |
| Member of Supervisory Committee | 6.1yrs | geen gegevens | geen gegevens |
8.9yrs
Gemiddelde duur
49yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van 3689 wordt beschouwd als ervaren (gemiddelde ambtstermijn 8.9 jaar).